Skip to main content
. 2019 May 30;20:35. doi: 10.1186/s40360-019-0315-9

Table 5.

Pooled estimates of antimicrobial resistance among Gram-negative bacterial isolates obtained from wound samples in Ethiopia

Antimicrobials Pooled estimates of resistant isolates (Proportion)
E. coli P. aeruginosa K. pneumoniae P. mirabilis
ES (95% CI) I2 (%) ES (95% CI) I2 (%) ES (95% CI) I2 (%) ES (95% CI) I2 (%)
AMO 0.73 (0.63, 0.83) 55.70 0.87 (0.82, 0.92) 0.00 0.90 (0.83, 0.97) 43.97 0.75 (0.57, 0.93) 86.81
AMC 0.57 (0.44, 0.70) 74.51 0.77 (0.63, 0.91) 63.67 0.67 (0.51, 0.83) 78.01 0.45 (0.36, 0.54) 19.01
AMP 0.84 (0.76, 0.91) 75.08 0.95 (0.92, 0.99) 0.00 0.88 (0.83, 0.93) 24.27 0.78 (0.70, 0.85) 39.67
CIP 0.27 (0.16, 0.37) 86.99 0.16 (0.09, 0.24) 87.63 0.29 (0.15, 0.42) 85.50 0.12 (0.06, 0.19) 73.68
CRO 0.45 (0.31, 0,60) 89.81 0.58 (0.35, 0.82) 95.86 0.57 (0.39, 0.75) 92.32 0.43 (0.24, 0.63) 94.04
SXT 0.53 (0.43, 0.64) 75.91 0.76 (0.68, 0.85) 51.82 0.64 (0.51, 0.77) 76.58 0.56 (0.39, 0.72) 88.19
GEN 0.24 (0.16, 0.33) 93.09 0.18 (0.11, 0.26) 66.47 0.37 (0.22, 0.52) 89.66 0.21 (0.12, 0.30) 74.31

AMO Amoxicillin, AMP Ampicillin, AMC Amoxicillin-clavulanic acid, SXT Cotrimoxazole, CRO Ceftriaxone, CIP Ciprofloxacin, GEN Gentamicin